Euclises Pharmaceuticals IncCompany Details

Get alertedif Euclises Pharmaceuticals Inc gets funded!
United States
St. Louis
Industry:Medical devices and equipment
Detailed industries:biotechnology
Company description

Euclises Pharmaceuticals, Inc. (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib® platform and is in the process of selecting a lead clinical development candidate.


Funding history

Create alert
Want to know when Euclises Pharmaceuticals Inc gets funded?
Key people
Robert Alan BeardsleyChair, Board of Directors, Executive Chair
Robert CalcaterraDirector
Raj DevrajPresident & CEO
Rajesh DevrajDirector, Executive Officer
Robert KarrDirector, Executive Officer
Eduardo MartinezDirector
Bobby W SandagePresident & CEO
Bobby Sandage, Jr.Director, Executive Officer
John TalleyChief Scientific Officer, Director
Randall Weissco-founder
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!